← Back to Patent Explorer
US4304715A Expired / Lapsed US ⏱️ 0.0 years remaining

Enkephalin analogues

Assignee: Individual
•
Filing: 1980-01-14
•
Granted: 1981-12-08
•
Expires: 2000-01-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds corresponding in structure to enkephalin or polypeptide analogues thereof, wherein one or more peptide links of the enkephalin or analogue is represented by a group or groups the same or different selected from dimethylene, hydroxydimethylene, methylene-imino and ketomethylene groups and/or wherein adjacent peptide bond nitrogen atoms are linked by a carbonyl or thiocarbonyl group.

Inventors

  • 👤 Derek Hudson
  • 👤 Robert Sharpe
  • 👤 Michael Szelke

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 16:09
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06008; C07K5/06078; C07K5/02; C07K5/0207; C07K5/08; C07K5/0802; C07K5/0804; C07K5/0812

Claims Analysis

Total Claims: 30
Claim 1
Independent Claim 212 words
Compounds of the general formula R-Tyr-X-Gly-B-Y-Z where (a) --X is Gly, aza-Gly, aza-Ala or any D-amino acid residue --B is Phe, N-substituted (particularly N-methyl) -Phe or dehydro-Phe all optionally substituted in the ring, or alternatively cyclohexylalanine --Y is any D- or L-amino acid residue and (b) one or more of the peptide links between Tyr, X, Gly, B and Y is replaced by a group or groups, the same or different, selected from --CH(OH)--CH 2 --, --CH(OR)--CH 2 --, --CH 2 NH--, ##STR34## --CH 2 --NR--, --CO--CH 2 --and (except where X-Gly and the Gly-Gly link is involved) --CH 2 CH 2 -- (where R is an aliphatic or other protective group) and/or any adjacent pair of peptide-bond nitrogen atoms of the backbone is linked to form the structure ##STR35## that is to say a carbonyl or thiocarbonyl group links the nitrogen atoms of adjacent amino acid residues, A and A' being the side chains thereof and optionally further with the nitrogen of one or more remaining peptide groups carrying a protective aliphatic or other group as ##STR36## where R is as below and (c) Z is --NH 2 , --NHR, --N(R) 2 , --OH or --OR where R is as below and (d) R is an aliphatic or other protective group.
Claim 2
Dependent Claim 212 words
Compounds of the general formula R-Tyr-X-Gly-B-Y-Z where (a) --X is Gly, aza-Gly, aza-Ala or any D-amino acid residue --B is Phe, N-substituted (particularly N-methyl) -Phe or dehydro-Phe all optionally substituted in the ring, or alternatively cyclohexylalanine --Y is any D- or L-amino acid residue and (b) one or more of the peptide links between Tyr, X, Gly, B and Y is replaced by a group or groups, the same or different, selected from --CH(OH)--CH 2 --, --CH(OR)--CH 2 --, --CH 2 NH--, ##STR34## --CH 2 --NR--, --CO--CH 2 --and (except where X-Gly and the Gly-Gly link is involved) --CH 2 CH 2 -- (where R is an aliphatic or other protective group) and/or any adjacent pair of peptide-bond nitrogen atoms of the backbone is linked to form the structure ##STR35## that is to say a carbonyl or thiocarbonyl group links the nitrogen atoms of adjacent amino acid residues, A and A' being the side chains thereof and optionally further with the nitrogen of one or more remaining peptide groups carrying a protective aliphatic or other group as ##STR36## where R is as below and (c) Z is --NH 2 , --NHR, --N(R) 2 , --OH or --OR where R is as below and (d) R is an aliphatic or other protective group.
Claim 3
Dependent Claim 47 words
Compounds according to claim 1, where A and A' are selected from the side chains of glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, cystine, methionine, tryptophan, aspartic acid, glutamic acid, arginine, lysine and histidine as such or in protected or modified form.
Claim 4
Dependent Claim 187 words
Compounds according to claim 1, wherein A and A' are selected from one of the following combinations (i) A as the side chain of Gly, aza-Gly, aza-Ala or any D-amino acid residue particularly D-Ala, D-Thr, D-Ser or D-Met, and A' as the side chain of Gly, (ii) A as the side chain of Gly and A' as the side chain of Phe, N-substituted (particularly N-methyl)-Phe or dehydro-Phe all optionally substituted in the ring by hydroxy, halo, nitro or other groups, or alternatively cyclohexylalanine (iii) A as the side chain of Phe, N-substituted (particularly N-methyl) -Phe or dehydro-Phe all optionally substituted in the ring by hydroxy, halo, nitro or other groups, or alternatively cyclohexylalanine, and A' as any D- or L-amino acid residue particularly Leu, Nle, Met or the sulphoxide of Met all as such or in aza form; Pro or Hypro; or homoserine lactone; or formal derivatives of any of these in which the terminal ##STR37## group is replaced by --CH 2 --Z (Z is --NH 2 , --NHR, --N(R) 2 , --OH or --OR where R is an aliphatic or other protective group) or by hydrogen.
Claim 5
Dependent Claim 16 words
Compounds according to claim 1, 2 or 3 wherein X is D-Ala, D-Thr, D-Ser or D-Met.
Claim 6
Dependent Claim 22 words
Compounds according to claim 1, 2 or 3, wherein ring substituents in B are selected from hydroxy, halogen, nitro or other groups.
Claim 7
Dependent Claim 66 words
Compounds according to claim 1, 2 or 3 wherein Y is a D or L amino acid selected from Leu, Nle, Met or the sulphoxide of Met, all as such or in aza form; Pro or Hypro; or homoserine lactone; or formal derivatives of any of these in which the terminal ##STR38## group is replaced by --CH 2 --Z (Z as claim 2) or by hydrogen.
Claim 8
Dependent Claim 93 words
Compounds according to claim 1, 2 or 3, wherein R is selected from methyl, ethyl, propyl, cyclopropyl, cyclopropylmethyl, butyl, allyl, phenyl, benzyl or the like or simple halogenated (in particular fluorinated) derivatives thereof; formyl, acetyl or other acyl groups or simple halosubstituted derivatives thereof such as chloroacetyl or trifluoroacetyl; or a substituted derivative such as ##STR39## where R 1 may be methyl, ethyl, propyl, cyclopropyl, cyclopropylmethyl, butyl, allyl or the like, or phenyl, or benzyl or ring substituted phenyl or benzyl derivatives, tertiary butyl, or substituted derivatives such as phenylisopropyl, diphenylisopropyl or fluorenylmethylene.
Claim 9
Dependent Claim 8 words
The compound ##STR40## wherein Z' is benzyloxycarbonyl ##STR41##
Claim 10
Dependent Claim 8 words
The compound ##STR40## wherein Z' is benzyloxycarbonyl ##STR41##
Claim 11
Dependent Claim 3 words
The compound: ##STR42##
Claim 12
Dependent Claim 3 words
The compound: ##STR42##
Claim 13
Dependent Claim 7 words
The compound: ##STR43## (Z' as claim 8).
Claim 14
Dependent Claim 3 words
The compound: ##STR44##
Claim 15
Dependent Claim 3 words
The compound: ##STR44##
Claim 16
Dependent Claim 7 words
The compound: ##STR45## (Z' as claim 8).
Claim 17
Dependent Claim 3 words
The compound: ##STR46##
Claim 18
Dependent Claim 3 words
The compound: ##STR46##
Claim 19
Dependent Claim 3 words
The compound: ##STR47##
Claim 20
Dependent Claim 3 words
The compound: ##STR47##
Claim 21
Dependent Claim 3 words
The compound: ##STR48##
Claim 22
Dependent Claim 3 words
The compound: ##STR48##
Claim 23
Dependent Claim 7 words
The compound: ##STR49## (Z' as claim 8).
Claim 24
Dependent Claim 3 words
The compound: ##STR50##
Claim 25
Dependent Claim 3 words
The compound: ##STR50##
Claim 26
Dependent Claim 7 words
The compound: ##STR51## (Z' as claim 8).
Claim 27
Dependent Claim 3 words
The compound: ##STR52##
Claim 28
Dependent Claim 3 words
The compound: ##STR52##
Claim 29
Dependent Claim 7 words
The compound: ##STR53## (Z' as claim 8).
Claim 30
Dependent Claim 32 words
A compound according to any one of the preceding claims, as such or in pharmaceutically acceptable N-protected or salt form, when made up with a pharmaceutically acceptable diluent or carrier for administration.

References Cited (Backward Citations)

US4028319A Cited
US4198398A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-12-07 1985-06-08 1985-12-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-12-07 1989-06-08 1989-12-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-12-07 1993-06-08 1993-12-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag